VRTX · News · 20260825N
Licensing / Collaboration Deals
VERTEX PHARMACEUTICALS INC / MA · 2026-08-25 · Importance 31 · Surprise 42 · In source text
AbCellera Biologics reported a new collaboration with Vertex Pharmaceuticals in connection with its ABCL635 hot-flash drug program. The report did not disclose the collaboration’s financial terms, scope, development milestones, or geographic rights. The partnership was presented alongside positive Phase 2 ABCL635 data and AbCellera’s shift toward a pipeline-and-platform business model.
Key facts
- A new collaboration with Vertex Pharmaceuticals was announced in connection with AbCellera Biologics Inc.'s ABCL635 program. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | probable | — | A new collaboration with Vertex Pharmaceuticals was announced in connection with AbCellera Biologics Inc.'s ABCL635 program. |